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Introduction
TNF receptor associated periodic syndrome (TRAPS) is a
rare autosomal dominant disease characterized by epi-
sodes of fever usually lasting two to three weeks, asso-
ciated with severe abdominal pain, arthralgia, skin rash
and red and swollen eyes. The age of onset varies from
early childhood to adulthood, and the disease affects both
sexes equally. Although first cases were described in indi-
viduals of Irish-Scottish descent, TRAPS has since been
reported world-wide.
Case report
A 41 year old British man, with no family history, pre-
sented in early adolescence with episodes of severe
abdominal pain for which he had an appendectomy at the
age of 12. He had 10 to 12 attacks per year each lasting
almost exactly two weeks accompanied by a headache,
abdominal pain, arthralgia, myalgia, night sweats, general-
ised erythema and unilateral non-painful cervical lympha-
denopathy. He had occasional red eyes but no periorbital
oedema or periorbital pain. His puberty was relatively late
and he is significantly shorter than his siblings. During
attacks his inflammatory markers, serum amyloid A pro-
tein (SAA) and C-reactive protein (CRP), were elevated to
median values of 258 mg/L (range 60 – 679) and 46 mg/L
(range 30 – 96) respectively. He is in full time employment
and remains physically extremely fit.
He underwent screening of the four genes associated
with periodic fever syndrome: MEFV (the gene associated
with FMF); TNFRSF1A (the gene associated with TRAPS)
NLRP3 (the gene associated with CAPS) and MVK (the
gene associated with MKD).
A novel in frame deletion of 24 nucleotides (c.255_
278del) in exon 3 of the TNFRSF1A gene was identified by
PCR and Sanger sequencing and subsequently confirmed
with allele-specific PCR by using primers complementary
to the sequence of a mutant DNA. Screening of parental
DNA showed no evidence of nucleotide alternation in
their TNFRSF1A gene suggesting that the deletion identi-
fied in our patient was a de novo mutation.
He commenced treatment with anakinra, to which had
a dramatic response with a rapid resolution of symptoms
and normalization in SAA and CRP to healthy levels of
8.1 and 4 mg/L.
Discussion
Genetic aberrations in tumor necrosis factor receptor
superfamily 1A gene (TNFRSF1A) located on chromo-
some 12p13 are the cause of TRAPS. To date, 89 variants
have been reported to be associated with clinical TRAPS,
of which 95% are single nucleotide substitutions.
The novel mutation identified in our patient results in
a deletion of eight amino acids p.Ser86_Glu93del (Infever
description S57_E64del) in the second domain of the
tumor necrosis factor receptor superfamily member 1A
protein (TNFR1).
Based on the crystal structure of TNFR1 proposed by
Banner et al, residues from Ser57 to Phe60 are structurally
conserved between the second and third extracellular
domains. Additionally Phe60 residue is crucial for proper
domain 2 folding and its side chain further stabilizes the
structure by interacting with both the second disulfide
bridge and the Ser-74-Asp-93 hydrogen bond bridge. It is
therefore very likely that the novel variant we have identi-
fied produces profound changes to the three dimensional
shape of the TNFR1 impairing its folding and binding
with TNF.
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